470 related articles for article (PubMed ID: 22365299)
61. Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma.
Liu X; Li J; Qu X; Yan W; Zhang L; Zhang S; Yang C; Zheng J
Medicine (Baltimore); 2016 May; 95(20):e3431. PubMed ID: 27196448
[TBL] [Abstract][Full Text] [Related]
62. [Vascular tumors and pseudotumors. Kaposiform hemangioendothelioma].
Wassef M
Ann Pathol; 2011 Aug; 31(4):260-5. PubMed ID: 21839349
[No Abstract] [Full Text] [Related]
63. Bifocal Tibial Kaposiform Hemangioendothelioma Responsive to Vincristine Therapy: A Case Report.
Bsisu IK; Alkharabsheh MM; Al-Zu'bi BB; Almuhaisen G; Awidi AS; Samarah OQ
Am J Case Rep; 2019 Dec; 20():1923-1929. PubMed ID: 31866667
[TBL] [Abstract][Full Text] [Related]
64. Treatment of Corticosteroid-Resistant Vascular Tumors Associated with the Kasabach-Merritt Phenomenon in Infants: An Approach with Transcatheter Arterial Embolization Plus Vincristine Therapy.
Tan X; Chen M; Zhang J; Zhou S; Shen G; Liu Z; Jiang H; Xia J
J Vasc Interv Radiol; 2016 Apr; 27(4):569-75. PubMed ID: 26898623
[TBL] [Abstract][Full Text] [Related]
65. Treatment of kaposiform hemangioendothelioma and tufted angioma.
Liu XH; Li JY; Qu XH; Yan WL; Zhang L; Yang C; Zheng JW
Int J Cancer; 2016 Oct; 139(7):1658-66. PubMed ID: 27252149
[TBL] [Abstract][Full Text] [Related]
66. Kaposiform hemangioendothelioma: current knowledge and future perspectives.
Ji Y; Chen S; Yang K; Xia C; Li L
Orphanet J Rare Dis; 2020 Feb; 15(1):39. PubMed ID: 32014025
[TBL] [Abstract][Full Text] [Related]
67. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
Wang Z; Li K; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2014 Aug; 61(8):1518-9. PubMed ID: 24482015
[No Abstract] [Full Text] [Related]
68. Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma.
Kai L; Wang Z; Yao W; Dong K; Xiao X
J Cancer Res Clin Oncol; 2014 Mar; 140(3):471-6. PubMed ID: 24464150
[TBL] [Abstract][Full Text] [Related]
69. Kasabach-Merritt syndrome, kaposiform haemangioendothelioma and platelet blockade.
O'Rafferty C; O'Regan GM; Irvine AD; Smith OP
Br J Haematol; 2015 Oct; 171(1):11. PubMed ID: 26114338
[No Abstract] [Full Text] [Related]
70. Giant retroperitoneal Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: A case report.
Wu D; Xu J; Wang P; Zhou S
Asian J Surg; 2023 Feb; 46(2):1014-1015. PubMed ID: 35961905
[No Abstract] [Full Text] [Related]
71. A Case Report of 2 Sirolimus-Related Deaths Among Infants With Kaposiform Hemangioendotheliomas.
Ying H; Qiao C; Yang X; Lin X
Pediatrics; 2018 Apr; 141(Suppl 5):S425-S429. PubMed ID: 29610165
[TBL] [Abstract][Full Text] [Related]
72. Sirolimus combined with glucocorticoids in the treatment of Kasabach-Merritt phenomenon in a neonate: A case report.
Cheng J; Zou Y; Fu R; Jin P; Huang M; Wu Z; Bai H; Huang X; Yuan H
Medicine (Baltimore); 2024 Apr; 103(14):e37706. PubMed ID: 38579031
[TBL] [Abstract][Full Text] [Related]
73. Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences.
Ji Y; Chen S; Peng S; Xia C; Li L
Orphanet J Rare Dis; 2019 Jul; 14(1):165. PubMed ID: 31277673
[TBL] [Abstract][Full Text] [Related]
74. Kaposiform hemangioendothelioma (with Kasabach Merritt syndrome) of the head and neck: case report and review of the literature.
Mukerji SS; Osborn AJ; Roberts J; Valdez TA
Int J Pediatr Otorhinolaryngol; 2009 Oct; 73(10):1474-6. PubMed ID: 19643504
[TBL] [Abstract][Full Text] [Related]
75. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
[No Abstract] [Full Text] [Related]
76. Congenital fulminant Kaposiform hemangioendothelioma of the leg.
Ergaz Z; Bar-Oz B; Vainer GW; Abu-Leil S; Simanovsky N; Diav-Citrin O
Reprod Toxicol; 2014 Dec; 50():1-3. PubMed ID: 25277314
[TBL] [Abstract][Full Text] [Related]
77. Congenital kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon successfully treated with low-dose radiation therapy.
Malhotra Y; Yang CS; McNamara J; Antaya RJ
Pediatr Dermatol; 2014; 31(5):595-8. PubMed ID: 23458157
[TBL] [Abstract][Full Text] [Related]
78. Successful Management of Pancreatic Kaposiform Hemangioendothelioma With Sirolimus: Case Report and Literature Review.
Wang C; Li Y; Xiang B; Li F; Chen S; Li L; Ji Y
Pancreas; 2017; 46(5):e39-e41. PubMed ID: 28426496
[No Abstract] [Full Text] [Related]
79. Outcome of Kasabach-Merritt phenomenon: the role of vincristine as monotherapy: report of a case.
Traivaree C; Lumkul R; Torcharus K; Krutuecho T; Sriphaisal T
J Med Assoc Thai; 2012 May; 95 Suppl 5():S181-5. PubMed ID: 22934467
[TBL] [Abstract][Full Text] [Related]
80. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: successful treatment with sirolimus.
Reichel A; Hamm H; Wiegering V; Wiewrodt B; Neubauer H; Ernestus K; Winkler B
J Dtsch Dermatol Ges; 2017 Mar; 15(3):329-331. PubMed ID: 28220608
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
